Research at NOVA Medical School takes a new step in understanding Alzheimer’s DiseaseThe NOVA Medical School research group in “Neuronal Trafficking in Aging”, led by Cláudia Almeida, has made a discovery impacting the understanding of the pathobiology of late-onset Alzheimer’s Disease. The study, recently published in Journal of Neuroscience, revealed that the gene CD2AP, identified as a genetic risk factor for the disease’s development, plays an essential role in the structure and function of synapses – contact points for communication between neurons – that are fundamental for maintaining neuronal functions such as memory.

Learn more here.

 

ITQB NOVA researcher Ana Pina has been awarded a 1M€ CaixaResearch Health grant to work on the early detection of neurodegenerative diseases through the study of tau protein aggregates. Pedro Mateus, Pedro Matos Pereira and Beatriz Royo, from ITQB NOVA, will also be working on this project, in collaboration with Cláudia Almeida, from Nova Medical School, and partners from NOVA FCT, Universitat de Barcelona and Unidade Local de Saúde de Lisboa Ocidental.

More information here.

  

The iBET’s CEO, Paula Alves, was honored with the “Prémio de Personalidade de Mérito” (Merit Personality Award) by APIFARMA – Portuguese Association of the Pharmaceutical Industry in a ceremony held on November 20^th. This award recognized Paula Alves’ contribution to the advancement of precision therapies through close collaboration with the Pharmaceutical Industry and clinicians, a research effort recognized at the international level.

Read more here.